ADMA Quote, Trading Chart, ADMA Biologics Inc

$2.475 Last:

0.2% Change Percent:

$2.4787 Open:

$2.475 Previous Close:

$2.55 High:

$2.432 Low:

1,808,864 Volume:

02/24/2021 03:40:17 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2021-02-24	2.4787	2.475	2.55	2.432	1,808,864
2021-02-23	2.47	2.47	2.495	2.222	3,976,266
2021-02-22	2.59	2.56	2.615	2.545	2,373,855
2021-02-19	2.69	2.6	2.72	2.58	3,468,426
2021-02-18	2.67	2.64	2.69	2.49	4,148,496
2021-02-17	2.69	2.63	2.7	2.47	3,447,460
2021-02-16	2.8484	2.65	2.86	2.65	4,326,982
2021-02-15	2.89	2.79	2.9	2.78	2,822,687
2021-02-12	2.89	2.79	2.9	2.78	2,799,213
2021-02-11	2.91	2.89	2.95	2.77	4,968,152
2021-02-10	3.03	2.88	3.1105	2.77	7,181,646
2021-02-09	2.95	2.95	2.99	2.79	7,561,083
2021-02-08	2.63	2.74	2.74	2.6	5,562,835
2021-02-05	2.68	2.6	2.68	2.49	3,531,138
2021-02-04	2.61	2.66	2.74	2.56	4,488,253
2021-02-03	2.4775	2.7	2.9	2.44	8,440,408
2021-02-02	2.46	2.44	2.49	2.37	3,335,293
2021-02-01	2.35	2.45	2.48	2.28	5,022,056
2021-01-29	2.17	2.22	2.27	2.15	2,692,061
2021-01-28	2.2959	2.17	2.2996	2.16	3,278,266

Stock Information

ADMA Biologics Inc Company Name:

ADMA Stock Symbol:

NASDAQ Market:

ADMA Biologics Inc Website:

ADMA Quote, Trading Chart, ADMA Biologics Inc

Get ADMA Alerts

News, Short Squeeze, Breakout and More Instantly...

ADMA - ADMA Biologics to Participate in Raymond James Institutional Investor Conference

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived bi...
ADMA - ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN

RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., Feb. 01, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, t...
ADMA - ADMA Biologics Receives Unique Permanent J-Code for ASCENIV(TM)

RAMSEY, N.J. and BOCA RATON, Fla., Jan. 26, 2021 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that the Centers for Medicare...